138 related articles for article (PubMed ID: 11772943)
1. Aldose reductase activation is a key component of myocardial response to ischemia.
Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
[TBL] [Abstract][Full Text] [Related]
2. Central role for aldose reductase pathway in myocardial ischemic injury.
Hwang YC; Kaneko M; Bakr S; Liao H; Lu Y; Lewis ER; Yan S; Ii S; Itakura M; Rui L; Skopicki H; Homma S; Schmidt AM; Oates PJ; Szabolcs M; Ramasamy R
FASEB J; 2004 Aug; 18(11):1192-9. PubMed ID: 15284219
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Ramasamy R; Oates PJ; Schaefer S
Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion.
Ramasamy R; Trueblood N; Schaefer S
Am J Physiol; 1998 Jul; 275(1):H195-203. PubMed ID: 9688914
[TBL] [Abstract][Full Text] [Related]
6. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium.
Hwang YC; Bakr S; Ellery CA; Oates PJ; Ramasamy R
FASEB J; 2003 Dec; 17(15):2331-3. PubMed ID: 14525943
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.
Trueblood N; Ramasamy R
Am J Physiol; 1998 Jul; 275(1):H75-83. PubMed ID: 9688898
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
Kaneko M; Bucciarelli L; Hwang YC; Lee L; Yan SF; Schmidt AM; Ramasamy R
Ann N Y Acad Sci; 2005 Jun; 1043():702-9. PubMed ID: 16037296
[TBL] [Abstract][Full Text] [Related]
10. Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart.
Brunner F
J Mol Cell Cardiol; 1997 Sep; 29(9):2363-74. PubMed ID: 9299360
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.
Kaiserova K; Tang XL; Srivastava S; Bhatnagar A
J Biol Chem; 2008 Apr; 283(14):9101-12. PubMed ID: 18223294
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.
Ramasamy R; Liu H; Oates PJ; Schaefer S
Cardiovasc Res; 1999 Apr; 42(1):130-9. PubMed ID: 10435004
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury.
Tracey WR; Magee WP; Ellery CA; MacAndrew JT; Smith AH; Knight DR; Oates PJ
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1447-52. PubMed ID: 11009428
[TBL] [Abstract][Full Text] [Related]
15. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
Kolb NS; Hunsaker LA; Vander Jagt DL
Mol Pharmacol; 1994 Apr; 45(4):797-801. PubMed ID: 8183257
[TBL] [Abstract][Full Text] [Related]
17. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
18. Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia.
Kawahara K; Hachiro T; Yokokawa T; Nakajima T; Yamauchi Y; Nakayama Y
J Mol Cell Cardiol; 2006 Jan; 40(1):35-46. PubMed ID: 16324709
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide signaling in ischemic heart.
Maulik N; Engelman DT; Watanabe M; Engelman RM; Maulik G; Cordis GA; Das DK
Cardiovasc Res; 1995 Oct; 30(4):593-601. PubMed ID: 8575007
[TBL] [Abstract][Full Text] [Related]
20. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts.
Sun HY; Xue FS; Xu YC; Li CW; Xiong J; Liao X; Zhang YM
Chin Med J (Engl); 2009 Dec; 122(24):3048-54. PubMed ID: 20137500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
